Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| natural killer cell | 12 studies | 31% ± 15% | |
| CD16-positive, CD56-dim natural killer cell, human | 9 studies | 25% ± 11% | |
| CD8-positive, alpha-beta T cell | 9 studies | 29% ± 14% | |
| T cell | 8 studies | 34% ± 13% | |
| CD16-negative, CD56-bright natural killer cell, human | 7 studies | 28% ± 12% | |
| effector memory CD8-positive, alpha-beta T cell | 7 studies | 28% ± 15% | |
| mature NK T cell | 6 studies | 25% ± 10% | |
| regulatory T cell | 6 studies | 24% ± 9% | |
| mucosal invariant T cell | 5 studies | 29% ± 15% | |
| CD4-positive, alpha-beta T cell | 4 studies | 37% ± 12% | |
| lymphocyte | 4 studies | 43% ± 17% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 16% ± 1% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 22% ± 9% | |
| gamma-delta T cell | 3 studies | 17% ± 2% |
Insufficient scRNA-seq data for expression of SLFN12L at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 100% | 198.27 | 577 / 578 | 27% | 0.56 | 316 / 1155 |
| thymus | 98% | 104.18 | 638 / 653 | 17% | 0.35 | 100 / 605 |
| breast | 97% | 99.68 | 444 / 459 | 17% | 0.35 | 190 / 1118 |
| stomach | 89% | 52.53 | 321 / 359 | 17% | 0.32 | 48 / 286 |
| uterus | 86% | 42.34 | 147 / 170 | 18% | 0.35 | 82 / 459 |
| spleen | 100% | 349.43 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 99% | 129.72 | 1194 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 398.06 | 913 / 929 | 0% | 0 | 0 / 0 |
| esophagus | 66% | 28.77 | 952 / 1445 | 19% | 0.29 | 34 / 183 |
| intestine | 75% | 78.79 | 722 / 966 | 8% | 0.16 | 41 / 527 |
| prostate | 80% | 45.03 | 197 / 245 | 2% | 0.04 | 8 / 502 |
| bladder | 67% | 62.43 | 14 / 21 | 10% | 0.19 | 49 / 504 |
| liver | 71% | 28.84 | 161 / 226 | 3% | 0.06 | 14 / 406 |
| kidney | 53% | 32.42 | 47 / 89 | 21% | 0.45 | 189 / 901 |
| lymph node | 0% | 0 | 0 / 0 | 62% | 1.98 | 18 / 29 |
| skin | 44% | 14.64 | 797 / 1809 | 17% | 0.38 | 78 / 472 |
| ovary | 58% | 23.03 | 105 / 180 | 2% | 0.03 | 8 / 430 |
| pancreas | 33% | 10.07 | 107 / 328 | 16% | 0.24 | 28 / 178 |
| blood vessel | 48% | 25.37 | 638 / 1335 | 0% | 0 | 0 / 0 |
| heart | 46% | 16.33 | 397 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 42% | 0.65 | 19 / 45 |
| adrenal gland | 36% | 10.72 | 93 / 258 | 0% | 0.02 | 1 / 230 |
| brain | 29% | 9.42 | 761 / 2642 | 1% | 0.02 | 7 / 705 |
| muscle | 12% | 3.15 | 97 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.04 | 2 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0016020 | Cellular component | membrane |
| Gene name | SLFN12L |
| Protein name | Schlafen family member 12-like Schlafen family member 12 like |
| Synonyms | SLFN5 |
| Description | |
| Accessions | A0A8I5QCZ1 A0A499FJ85 Q6IEE8 ENST00000628453.4 ENST00000260908.13 |